{"id":"https://openalex.org/W2173136480","doi":"https://doi.org/10.2337/dc15-1531","title":"Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5","display_name":"Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-17","ids":{"openalex":"https://openalex.org/W2173136480","doi":"https://doi.org/10.2337/dc15-1531","mag":"2173136480","pmid":"https://pubmed.ncbi.nlm.nih.gov/26577417"},"language":"en","primary_location":{"id":"doi:10.2337/dc15-1531","doi":"https://doi.org/10.2337/dc15-1531","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc15-1531","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2173136480"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17615/d4gc-v603","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John B. Buse","raw_affiliation_strings":["University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020174004","display_name":"Helena W. Rodbard","orcid":"https://orcid.org/0000-0002-6187-8445","observed_orcids":["https://orcid.org/0000-0002-6187-8445"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helena W. Rodbard","raw_affiliation_strings":["Endocrine and Metabolic Consultants, Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine and Metabolic Consultants, Rockville, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103816142","display_name":"Carlos Trescol\u00ed Serrano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094134","display_name":"Hospital de La Ribera","ror":"https://ror.org/00qnmxq60","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094134"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlos Trescoli Serrano","raw_affiliation_strings":["Hospital de la Ribera, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital de la Ribera, Valencia, Spain","institution_ids":["https://openalex.org/I4210094134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113573488","display_name":"Junxiang Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Junxiang Luo","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068287587","display_name":"T. Iv\u00e1nyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tibor Ivanyi","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046986824","display_name":"Juliana M. Bue\u2010Valleskey","orcid":"https://orcid.org/0000-0002-9746-7744","observed_orcids":["https://orcid.org/0000-0002-9746-7744"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juliana Bue-Valleskey","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057894973","display_name":"Mark L. Hartman","orcid":"https://orcid.org/0000-0003-2396-7356","observed_orcids":["https://orcid.org/0000-0003-2396-7356"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark L. Hartman","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michelle A. Carey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120869","display_name":"inVentiv Health Clinical","ror":"https://ror.org/02mv4ab52","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210120869"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michelle A. Carey","raw_affiliation_strings":["inVentiv Health Clinical, Blue Bell, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"inVentiv Health Clinical, Blue Bell, PA","institution_ids":["https://openalex.org/I4210120869"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082380245","display_name":"Annette M. Chang","orcid":"https://orcid.org/0000-0003-0847-0333","observed_orcids":["https://orcid.org/0000-0003-0847-0333"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Annette M. Chang","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5082380245"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":11.1479,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.99141642,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"39","issue":"1","first_page":"92","last_page":"100"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9208999872207642,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0746999979019165,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9729999899864197},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.8420000076293945},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9210000038146973},{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/glycemic-variability","display_name":"glycemic variability","score":0.8650000095367432},{"id":"https://openalex.org/keywords/liver-fat-content","display_name":"liver fat","score":0.8190000057220459},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7580000162124634},{"id":"https://openalex.org/keywords/aminotransferases","display_name":"transaminases","score":0.9739999771118164},{"id":"https://openalex.org/keywords/insulin-dose","display_name":"insulin dose","score":0.46799999475479126},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.7160000205039978},{"id":"https://openalex.org/keywords/treat-to-target","display_name":"treat-to-target","score":0.6790000200271606},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8739676475524902},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.8138810992240906},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7654800415039062},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.7080470323562622},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6605978012084961},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6300727128982544},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6149338483810425},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5754719972610474},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5641906261444092},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3379512429237366}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2337/dc15-1531","doi":"https://doi.org/10.2337/dc15-1531","is_oa":false,"landing_page_url":"https://doi.org/10.2337/dc15-1531","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:26577417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26577417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:cdr.lib.unc.edu:m613n310p","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/d4gc-v603","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Care, 39(1)","raw_type":"Article"},{"id":"doi:10.17615/d4gc-v603","doi":"https://doi.org/10.17615/d4gc-v603","is_oa":true,"landing_page_url":"https://doi.org/10.17615/d4gc-v603","pdf_url":"http://cdr.lib.unc.edu/downloads/bk128h00c","source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:cdr.lib.unc.edu:m613n310p","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/d4gc-v603","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes Care, 39(1)","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309487","display_name":"Osiris Therapeutics","ror":"https://ror.org/03r8s5x58"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320315147","display_name":"Orexigen Therapeutics","ror":"https://ror.org/04cnvsy93"},{"id":"https://openalex.org/F4320315641","display_name":"Halozyme","ror":"https://ror.org/001x5ea44"},{"id":"https://openalex.org/F4320315955","display_name":"Quest Diagnostics","ror":"https://ror.org/010g9bb70"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2173136480.pdf","grobid_xml":"https://content.openalex.org/works/W2173136480.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1489794034","https://openalex.org/W1721477966","https://openalex.org/W1966710530","https://openalex.org/W1967501451","https://openalex.org/W1968865647","https://openalex.org/W1977102586","https://openalex.org/W1978154080","https://openalex.org/W1990200147","https://openalex.org/W1996645748","https://openalex.org/W2018732554","https://openalex.org/W2022069934","https://openalex.org/W2039618459","https://openalex.org/W2057595002","https://openalex.org/W2062583781","https://openalex.org/W2079089745","https://openalex.org/W2079248356","https://openalex.org/W2086989993","https://openalex.org/W2119870192","https://openalex.org/W2122596924","https://openalex.org/W2125430658","https://openalex.org/W2126781806","https://openalex.org/W2127521907","https://openalex.org/W2127854940","https://openalex.org/W2131037080","https://openalex.org/W2139425593","https://openalex.org/W2140467079","https://openalex.org/W2142370026","https://openalex.org/W2155961449","https://openalex.org/W2326227647","https://openalex.org/W6701521475"],"related_works":["https://openalex.org/W2406227915","https://openalex.org/W2469322296","https://openalex.org/W4251785080","https://openalex.org/W4247078845","https://openalex.org/W2491328855","https://openalex.org/W2530830060","https://openalex.org/W2531539547","https://openalex.org/W2604580255","https://openalex.org/W2749532988","https://openalex.org/W2314567644"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3],"efficacy":[4],"and":[5,145,172,178,193,210,212,251,265,271,275],"safety":[6],"of":[7,231],"basal":[8,29,202],"insulin":[9,13,30,203],"peglispro":[10],"(BIL)":[11],"versus":[12,94,152,218,241,260],"glargine":[14,62,95,219,242],"in":[15,88,125,228],"patients":[16,50,136,161,232],"with":[17,28,33,92,127,216,239,246,262],"type":[18],"2":[19],"diabetes":[20],"(hemoglobin":[21],"A1c":[22],"[HbA1c]":[23],"\u22649%":[24],"[75":[25],"mmol/mol])":[26,55],"treated":[27],"alone":[31],"or":[32,35,61],"three":[34],"fewer":[36],"oral":[37],"antihyperglycemic":[38],"medications.":[39],"RESEARCH":[40],"DESIGN":[41],"AND":[42],"METHODS:":[43],"This":[44],"52-week,":[45],"open-label,":[46],"treat-to-target":[47],"study":[48],"randomized":[49],"(mean":[51],"HbA1c":[52,74,89,126,138,163],"7.42%":[53],"[57.6":[54],"to":[56,75,111,118],"BIL":[57,93,128,135,151,217,240,255],"(n":[58,63,233],"=":[59,64,188,234],"307)":[60],"159).":[65],"The":[66],"primary":[67],"end":[68],"point":[69],"was":[70,90,129,157,197,205],"change":[71],"from":[72,237],"baseline":[73,238],"26":[76,85,144,171,192,250],"weeks":[77,143,174,186,191],"(0.4%":[78],"[4.4":[79],"mmol/mol]":[80,98],"noninferiority":[81],"margin).":[82],"RESULTS:":[83],"At":[84,190],"weeks,":[86],"reduction":[87,124],"superior":[91,257],"(-0.82%":[96],"[-8.9":[97],"vs.":[99],"-0.29%":[100],"[-3.2":[101],"mmol/mol];":[102],"least":[103],"squares":[104],"mean":[105],"difference":[106],"-0.52%,":[107],"95%":[108,115],"CI":[109,116],"-0.67":[110],"-0.38":[112],"[-5.7":[113],"mmol/mol,":[114],"-7.3":[117],"-4.2;":[119],"P":[120],"<":[121,148,176,200,208,221,244],"0.001);":[122],"greater":[123],"maintained":[130],"at":[131,142,170,184],"52":[132,146,173,185,252],"weeks.":[133,253],"More":[134],"achieved":[137,162],"<7%":[139,164],"(53":[140,165],"mmol/mol)":[141,166],"(P":[147,175,187,199,207,220,243],"0.001).":[149],"With":[150],"glargine,":[153,261],"nocturnal":[154,168,264],"hypoglycemia":[155,169,180],"rate":[156],"60%":[158],"lower,":[159],"more":[160],"without":[167],"0.001),":[177,209,245],"total":[179,266],"rates":[181],"were":[182,214],"lower":[183,198,268],"0.03).":[189],"52,":[194],"glucose":[195,269],"variability":[196],"0.01),":[201],"dose":[204],"higher":[206,215],"triglycerides":[211],"aminotransferases":[213],"0.05).":[222],"Liver":[223],"fat":[224],"content":[225],"(LFC),":[226],"assessed":[227],"a":[229],"subset":[230],"162),":[235],"increased":[236,272],"stable":[247],"levels":[248],"between":[249],"CONCLUSIONS:":[254],"provided":[256],"glycemic":[258],"control":[259],"reduced":[263],"hypoglycemia,":[267],"variability,":[270],"triglycerides,":[273],"aminotransferases,":[274],"LFC.":[276]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2173136480","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":27},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
